Easy, Accurate and Affordable Cancer Screening....Welcome to the Beacon Revolution!


  • 11:31
  • 10:38

Welcome To Beacon Biomedical

Beacon Biomedical Inc. is a medical diagnostic device company on a mission...to save as many lives as possible by providing easy, accurate and affordable blood tests for earlier cancer detection.
Our laboratory developed test (LDT) solutions are being developed for primary care providers to be able to screen their patients for the presence of undiagnosed cancer. Our focus is on getting individuals screened for cancer in order to improve earlier detection and survivability from these devastating diseases.

BeScreened™-CRC is Now Available To The Public!
Beacon is pleased to announce the release of our first blood-based screening test for the detection of  colorectal cancer (CRC).  It is called BeScreened™-CRC .  It's a CLIA approved laboratory developed test (LDT) that is 95% accurate at detecting stages I-IV CRC.  Additionally, in preliminary studies it has demonstrated greater than 60% sensitivity at detecting precancerous polys (advanced adenomas).  BeScreened™-CRC is now available through partnering Accountable Care Organizations (ACOs) and Independent Physician Offices. 

Practitioners interested in providing BeScreened-CRC to your screening non-compliant patients, please contact Beacon for more details. 

Individuals interested in getting our test should contact their healthcare provider, or Beacon to check on the test's availability in your area. 

​March is Colorectal Cancer Awareness Month. 

Did you know that colorectal cancer is actually preventable!  

Education and awareness surrounding the importance of colorectal cancer screening is critical to supporting early detection because early detection saves lives.  However, all the education and awareness really doesn’t matter if action is not taken.  As such, we urge all men and women over the age of 50 (or 45 if African American) who have not yet been screened for colorectal cancer to get screened….NOW!

Be Aware, Be Prepared & Get Screened for CRC.

To help you find out more about what you can do to prevent colorectal cancer and save a life, we are pleased to share the following resources and support organizations with you.
Centers for Disease Control and Prevention: Screening tests help prevent colorectal cancer by finding precancerous polyps (abnormal growths) so they can be removed. Screening also finds this cancer early, when treatment can be most effective. Colorectal cancer screening saves lives. If you’re 50 years old or older (45 if your African American), get screened! 
Colon Cancer Alliance: The Colon Cancer Alliance’s mission is to knock colon cancer out of the top three cancer killers. They are doing this by championing prevention, funding cutting-edge research and providing the highest quality patient support services.  

International Cancer Advocacy Network:  ICAN is a 501(C)(3) tax-exempt charitable organization providing direct patient navigation for Stage IV cancer cases throughout the United States and in more than 50 countries to date. ICAN is a global network consisting of a small staff and more than 1,100 volunteers, the leadership of which spans 17 time zones. 

American Cancer Society: Colorectal cancer is the third most commonly diagnosed cancer and the second leading cause of cancer death in both men and women in the US. The American Cancer Society estimates that 136,830 people will be diagnosed with colorectal cancer and 50,310 people will die this year from the disease. 
Arizona Digestive Health: Preventive Screening. Colon cancer is one of the most curable and preventable forms of cancer. You can take charge of your health and dramatically reduce your risk by having regular screenings. 

​​​​News and Events

March 2018

March is Colorectal Cancer (CRC) Awareness Month.  CRC is the most preventable cancer yet it remains the #2 killer when it comes to cancer deaths.  Our message to you is...Get Screened!  The life you save may very well be your own. ​

December 2017

Beacon Biomedical Inc.completed its non-clinical and clinical studies for BeScreened™-CRC and received its CLIA approval for clinical use as a blood-based colorectal screening test for screening non-compliant patients.  The test is 95% accurate and is now available to the public through partnered ACOs and Independent Physicians Offices.

Press Release

May 2017

​​Beacon Biomedical has  been selected as finalists to present at the 2017 Bio Start-up Stadium Event on June 22nd at Bio International Convention being held in San Diego June 18th-22nd. 

March 2017

March is Colorectal Cancer (CRC) Awareness Month.  Be Aware, Be Prepared & Get Screened for CRC.


February 2017
Beacon Biomedical Inc. receives its CLIA Laboratory ID (Number 03D2122615) from the Centers for Medicare & Medicaid Services, effective as of December 1, 2016

Beacon Biomedical Inc. and Sonora Quest Laboratories (SQL) have executed a Laboratory Draw Agreement giving Beacon access to all of SQL's Arizona-based Patient Service Centers and In-Office Phlebotomy locations. Beacon's clients and their patients will be able to have blood drawn, processed and shipped to Beacon's CLIA Laboratory for testing. This contract is in advance to Beacon's imminent market launch of its blood test for colorectal cancer screening, BeScreened-CRC.

September 2016

Beacon Biomedical Inc. is named an AZBio Fast Lane Honoree for 2016, will be honored during the 11th Annual

AZBio Awards Dinner on September 21st at the Phoenix Convention Center, and will be presenting at the AZBio White Hat Investors Conference on September 22nd.

July 2016

Beacon Biomedical Inc. Appoints Industry Veteran to Lead Cancer Screening Technology Commercialization.

Beacon Biomedical Inc. moves to new corporate offices and announces the opening of its new R&D and CLIA laboratory facilities.

June 2016

Beacon Biomedical Inc. to Present at Singular Research Spring Select "Best of the Uncovereds" Investment Conference on June 9, 2016

May 2016

Beacon Biomedical Inc. to Exhibit at BIO International Conference in San Francisco on June 6-9, 2016 

April 2016

Beacon Biomedical Inc. Appoints Industry Veteran To Lead Commercialization. Dave English had been appointed as Director of Business Development.

December 2015

Congratulations to Beacon Biomedical! They were named as 1 of the 6 winners in the Arizona Commerce Authority’s Fall 2015 round of the Arizona Innovation Challenge


Listen to Beacon Biomedical's CEO talk about their colon cancer screening test, ColoRT™ at ehealth radio https://t.co/mOMkMIMbDk

Beacon Biomedical, Inc., a privately held company focused on developing patient friendly cancer screening announced that it received an investment from Hyalescent Ventures.

October 2015

Beacon advances to the Semi-Finalist Round of the Arizona Commerce Authority's Fall 2015 Arizona Innovation Challenge as one of Top 25 Companies out of 131 applicants

September 2015

Beacon has been awarded a Phase I SBIR Grant for "Easy, Affordable & Accurate Point of Care Screening to Reduce Colorectal Cancer Disparities" from the National Institute of Biomedical Imaging and Biomedical Engineering at the National Institutes of Health.